$4.02
+0.1
(+2.55%)▲
2.49%
Downside
Day's Volatility :2.95%
Upside
0.47%
9.7%
Downside
52 Weeks Volatility :75.36%
Upside
72.71%
Period | Petmed Express Inc | Sector (Consumer Discretionary) | Index (Russel 2000) |
---|---|---|---|
3 Months | -2.49% | 2.7% | 0.0% |
6 Months | -41.58% | 5.2% | 0.0% |
1 Year | -72.59% | 5.2% | 0.0% |
3 Years | -86.11% | -2.2% | -20.2% |
Market Capitalization | 80.8M |
Book Value | $4.73 |
Dividend Share | 0.6 |
Dividend Yield | 15.54% |
Earnings Per Share (EPS) | -0.37 |
PEG Ratio | 2.58 |
Wall Street Target Price | 5.25 |
Profit Margin | -2.66% |
Operating Margin TTM | -5.75% |
Return On Assets TTM | -2.39% |
Return On Equity TTM | -7.22% |
Revenue TTM | 281.1M |
Revenue Per Share TTM | 13.78 |
Quarterly Revenue Growth YOY | 6.6000000000000005% |
Gross Profit TTM | 78.1M |
EBITDA | -394.0K |
Diluted Eps TTM | -0.37 |
Quarterly Earnings Growth YOY | -0.59 |
EPS Estimate Current Year | -0.19 |
EPS Estimate Next Year | -0.12 |
EPS Estimate Current Quarter | -0.07 |
EPS Estimate Next Quarter | -0.03 |
What analysts predicted
Upside of 30.6%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 283.4M | ↑ 3.51% |
Net Income | 37.7M | ↑ 1.23% |
Net Profit Margin | 13.32% | ↓ 0.3% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 284.1M | ↑ 0.25% |
Net Income | 25.9M | ↓ 31.5% |
Net Profit Margin | 9.1% | ↓ 4.22% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 309.2M | ↑ 8.83% |
Net Income | 23.9M | ↓ 7.47% |
Net Profit Margin | 7.74% | ↓ 1.36% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 273.4M | ↓ 11.58% |
Net Income | 18.7M | ↓ 21.75% |
Net Profit Margin | 6.85% | ↓ 0.89% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 256.9M | ↓ 6.06% |
Net Income | 233.0K | ↓ 98.76% |
Net Profit Margin | 0.09% | ↓ 6.76% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 281.1M | ↑ 9.42% |
Net Income | -7.5M | ↓ 3303.43% |
Net Profit Margin | -2.66% | ↓ 2.75% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 58.9M | ↓ 9.98% |
Net Income | -19.0K | ↓ 100.74% |
Net Profit Margin | -0.03% | ↓ 3.97% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 62.4M | ↑ 6.01% |
Net Income | -5.1M | ↑ 26752.63% |
Net Profit Margin | -8.18% | ↓ 8.15% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 78.2M | ↑ 25.38% |
Net Income | -887.0K | ↓ 82.61% |
Net Profit Margin | -1.13% | ↑ 7.05% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 71.0M | ↓ 9.26% |
Net Income | -70.0K | ↓ 92.11% |
Net Profit Margin | -0.1% | ↑ 1.03% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 65.3M | ↓ 8.0% |
Net Income | -2.0M | ↑ 2795.71% |
Net Profit Margin | -3.1% | ↓ 3.0% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 65.3M | ↑ 0.0% |
Net Income | -2.0M | ↑ 0.0% |
Net Profit Margin | -3.1% | ↑ 0.0% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 154.4M | ↑ 14.53% |
Total Liabilities | 19.7M | ↑ 3.36% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 155.3M | ↑ 0.58% |
Total Liabilities | 25.3M | ↑ 28.19% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 187.5M | ↑ 20.71% |
Total Liabilities | 46.2M | ↑ 82.58% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 176.3M | ↓ 5.96% |
Total Liabilities | 34.1M | ↓ 26.14% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 164.1M | ↓ 6.92% |
Total Liabilities | 40.3M | ↑ 18.13% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 175.1M | ↑ 6.69% |
Total Liabilities | 78.4M | ↑ 94.34% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 165.1M | ↓ 2.45% |
Total Liabilities | 31.5M | ↑ 1.36% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 164.1M | ↓ 0.61% |
Total Liabilities | 40.3M | ↑ 27.86% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 180.7M | ↑ 10.13% |
Total Liabilities | 62.4M | ↑ 54.79% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 159.3M | ↓ 11.88% |
Total Liabilities | 45.6M | ↓ 26.94% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 173.4M | ↑ 8.84% |
Total Liabilities | 73.3M | ↑ 60.72% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 173.4M | ↑ 0.0% |
Total Liabilities | 73.3M | ↑ 0.0% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 45.1M | ↑ 20.76% |
Investing Cash Flow | -620.0K | ↓ 11.81% |
Financing Cash Flow | -21.9M | ↑ 25.5% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 38.8M | ↓ 13.94% |
Investing Cash Flow | -2.3M | ↑ 272.74% |
Financing Cash Flow | -33.3M | ↑ 51.88% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 40.1M | ↑ 3.17% |
Investing Cash Flow | -2.4M | ↑ 5.24% |
Financing Cash Flow | -22.7M | ↓ 31.87% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 18.5M | ↓ 53.84% |
Investing Cash Flow | -1.8M | ↓ 27.96% |
Financing Cash Flow | -24.4M | ↑ 7.48% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 27.8M | ↑ 50.3% |
Investing Cash Flow | -10.3M | ↑ 485.62% |
Financing Cash Flow | -24.5M | ↑ 0.63% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 13.0M | ↓ 1119.73% |
Investing Cash Flow | -993.0K | ↓ 26.66% |
Financing Cash Flow | -6.1M | ↓ 2.34% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 9.7M | ↓ 25.03% |
Investing Cash Flow | -1.9M | ↑ 94.46% |
Financing Cash Flow | -6.1M | ↑ 0.64% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 562.0K | ↓ 94.22% |
Investing Cash Flow | -37.0M | ↑ 1816.73% |
Financing Cash Flow | -6.1M | ↓ 0.54% |
Sell
Neutral
Buy
Petmed Express Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Petmed Express Inc | -3.45% | -41.58% | -72.59% | -86.11% | -75.47% |
Walgreens Boots Alliance, Inc. | -26.5% | -49.63% | -62.69% | -75.64% | -79.09% |
Bimi International Medical Inc | -2.57% | -56.42% | -57.84% | -97.67% | -98.95% |
High Tide Inc | -15.53% | -3.65% | 45.67% | -69.82% | -79.44% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Petmed Express Inc | 1191.0 | NA | 2.58 | -0.19 | -0.07 | -0.02 | 0.16 | 4.73 |
Walgreens Boots Alliance, Inc. | 27.42 | NA | 1.98 | 2.63 | -0.56 | 0.01 | 0.09 | 15.8 |
Bimi International Medical Inc | NA | NA | NA | 0.0 | -1.04 | -0.13 | NA | 1.31 |
High Tide Inc | NA | NA | NA | -0.03 | -0.23 | 0.02 | NA | 1.76 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Petmed Express Inc | Sell | $80.8M | -75.47% | 1191.0 | -2.66% |
Walgreens Boots Alliance, Inc. | Hold | $9.9B | -79.09% | 27.42 | -3.99% |
Bimi International Medical Inc | NA | $18.8M | -98.95% | NA | -83.2% |
High Tide Inc | Buy | $156.7M | -79.44% | NA | -6.82% |
Insights on Petmed Express Inc
Revenue is down for the last 4 quarters, 78.24M → 65.31M (in $), with an average decrease of 5.8% per quarter
Netprofit is down for the last 3 quarters, -70.0K → -2.02M (in $), with an average decrease of 1397.9% per quarter
In the last 1 year, High Tide Inc has given 45.7% return, outperforming this stock by 118.3%
In the last 3 years, Petmed Express Inc has experienced a drawdown of -86.1%, however High Tide Inc resisted the overall trend and outperformed by 16.3%
BlackRock Inc
Renaissance Technologies Corp
Vanguard Group Inc
Hotchkis & Wiley Capital Management LLC
Mirae Asset Global Investments (Korea) Co Ltd
AQR Capital Management LLC
petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.
Organization | Petmed Express Inc |
Employees | 287 |
CEO | Mr. Mathew N. Hulett |
Industry | Retail Trade |
A Spac I Acquisition Corp
$4.02
+2.55%
Keyarch Acquisition Corp
$4.02
+2.55%
Connexa Sports Technologies Inc
$4.02
+2.55%
Us Value Etf
$4.02
+2.55%
First Wave Biopharma Inc
$4.02
+2.55%
Global X Msci Next Emerging
$4.02
+2.55%
Fat Projects Acquisition Corp
$4.02
+2.55%
Capital Link Global Fintech
$4.02
+2.55%
Applied Uv Inc
$4.02
+2.55%